MAPKAPK5
MAP kinase-activated protein kinase 5
Also known as: MAPK5_HUMAN, MK5, PRAK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IW41
- Gene
- MAPKAPK5
- Ensembl
- ENSG00000089022
- Chromosome
- 12
- Canonical length
- 473 aa
- Protein class
- Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a tumor suppressor and member of the serine/threonine kinase family. In response to cellular stress and proinflammatory cytokines, this kinase is activated through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38-alpha, and MAPK11/p38-beta. The encoded protein is found in the nucleus but translocates to the cytoplasm upon phosphorylation and activation. This kinase phosphorylates heat shock protein HSP27 at its physiologically relevant sites. Two alternately spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
473 residues, UniProt reviewed canonical sequence.
>Q8IW41|MAPKAPK5
1 MSEESDMDKA IKETSILEEY SINWTQKLGA GISGPVRVCV KKSTQERFAL KILLDRPKAR
61 NEVRLHMMCA THPNIVQIIE VFANSVQFPH ESSPRARLLI VMEMMEGGEL FHRISQHRHF
121 TEKQASQVTK QIALALRHCH LLNIAHRDLK PENLLFKDNS LDAPVKLCDF GFAKIDQGDL
181 MTPQFTPYYV APQVLEAQRR HQKEKSGIIP TSPTPYTYNK SCDLWSLGVI IYVMLCGYPP
241 FYSKHHSRTI PKDMRRKIMT GSFEFPEEEW SQISEMAKDV VRKLLKVKPE ERLTIEGVLD
301 HPWLNSTEAL DNVLPSAQLM MDKAVVAGIQ QAHAEQLANM RIQDLKVSLK PLHSVNNPIL
361 RKRKLLGTKP KDSVYIHDHE NGAEDSNVAL EKLRDVIAQC ILPQAGKGEN EDEKLNEVMQ
421 EAWKYNRECK LLRDTLQSFS WNGRGFTDKV DRLKLAEIVK QVIEEQTTSH ESQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAPKAPK5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 30 nTPM
- rectum: 29 nTPM
- choroid plexus: 28 nTPM
- small intestine: 27 nTPM
- colon: 26 nTPM
- bone marrow: 26 nTPM
Single-cell type
- respiratory ionocytes: 74 nCPM
- cardiomyocytes: 70 nCPM
- myonuclei: 65 nCPM
- enterocytes: 63 nCPM
- goblet cells: 61 nCPM
- erythrocyte progenitors: 57 nCPM
Immune cell
- non-classical monocyte: 8.8 nTPM
- T-reg: 4.8 nTPM
- gdT-cell: 4.2 nTPM
- naive CD4 T-cell: 4.2 nTPM
- memory B-cell: 3.6 nTPM
- classical monocyte: 3.3 nTPM
Brain region
- choroid plexus: 31 nTPM
- hippocampal formation: 29 nTPM
- cerebral cortex: 29 nTPM
- cerebellum: 29 nTPM
- basal ganglia: 27 nTPM
- hypothalamus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAPKAPK5.
Disease | AllUniProt
Conditions MAPKAPK5 is implicated in, by any mechanism.
- Neurocardiofaciodigital syndrome (NCFD) MIM:619869
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 87 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurocardiofaciodigital syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 2.42
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular senescence
- negative regulation of TOR signaling
- positive regulation of dendritic spine development
- positive regulation of telomere maintenance
- positive regulation of transcription by RNA polymerase II
- protein autophosphorylation
- Ras protein signal transduction
- regulation of signal transduction by p53 class mediator
- regulation of translation
- signal transduction
- stress-induced premature senescence
Molecular functions
- ATP binding
- calcium-dependent protein serine/threonine kinase activity
- calcium/calmodulin-dependent protein kinase activity
- calmodulin binding
- MAP kinase kinase activity
- mitogen-activated protein kinase binding
- p53 binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAPKAPK5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAPKAPK5 as an antibody target. Whether an autoantibody or antibody against MAPKAPK5 could matter depends on whether native MAPKAPK5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAPKAPK5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAPKAPK5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...